Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?
Clicks: 218
ID: 271443
2018
In Germany, direct-acting antiviral treatment of former or current drug users with or without opioid substitution therapy can achieve equally high sustained virological response rates as in patients with no history of drug use.
| Reference Key |
s2018addictiondirect-acting
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Christensen S;Buggisch P;Mauss S;Böker KHW;Schott E;Klinker H;Zimmermann T;Weber B;Reimer J;Serfert Y;Wedemeyer H;; |
| Journal | addiction (abingdon, england) |
| Year | 2018 |
| DOI | DOI not found |
| URL | |
| Keywords |
hepatitis c
germany
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
male
aged
middle aged
odds ratio
antiviral agents / therapeutic use*
chronic / complications
chronic / drug therapy*
registries
opiate substitution treatment*
Opioid-Related Disorders / complications
Opioid-Related Disorders / drug therapy*
Sustained Virologic Response*
pmid:29359361
doi:10.1111/add.14128
stefan christensen
peter buggisch
heiner wedemeyer
lost to follow-up*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.